Skip to main content
. 2020 May 16;26(4):565–585. doi: 10.1093/humupd/dmaa009

Figure 4.

Figure 4

Endometriosis phenotype may affect the therapeutic response to progestins. The graphs summarise dysmenorrhea (A) and deep dyspareunia (B) scores obtained by visual analogue scale (VAS) in women with rectovaginal endometriosis (Ferrero et al., 2009) and in women with ovarian endometrioma (Ferrero et al., 2014) treated with norethisterone acetate for 6 months. Data were extracted from published tables of two separate studies and plotted together for better visualisation.